Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease

Annals of Hematology

Volumn 81, Issue 11, 2002, Pages 659-661

  Au, W Y ^a   Ma, S K ^a   Chung, L P ^a   Chim, C S ^a   Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Arsenic; Gestational trophoblastic disease; Mantle cell lymphoma; Secondary APL

Indexed keywords

ALKYLATING AGENT; ARSENIC; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; ISONIAZID; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PROCARBAZINE; RETINOIC ACID; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHEMOTHERAPY; DISEASE ACTIVITY; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MANTLE CELL LYMPHOMA; MISSED ABORTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REMISSION; TROPHOBLASTIC DISEASE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ARSENICALS; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LYMPHOMA, MANTLE-CELL; MALE; NEOPLASMS, SECOND PRIMARY; OXIDES; PREGNANCY; TRETINOIN;

EID: 0036938435     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0552-6     Document Type: Article

References (16)

1. Giles FJ, Koeffler HP (1994) Secondary myelodysplastic syndromes and leukemias. Curr Opin Hematol 1:256-260
2. Rowley JD, Olney HJ (2002) International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 33:331-345
3. Andersen MK, Larson RA, Mauritzson N, Schnittger S, Jhanwar SC, Pedersen-Bjergaard J (2002) Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33:395-400
4. Kwong YL, Wong KF, Chan TK (1995) Trisomy 8 in acute promyelocytic leukaemia: an interphase study by fluorescence in situ hybridization. Br J Haematol 90:697-700
5. Chim CS, Chan AC, Choo CK, Kwong YL, Lie AK, Liang R (1998) Mantle cell lymphoma in the Chinese: clinicopathological features and treatment outcome. Am J Hematol 59:295-301
6. Gillis S, Sofer O, Zelig O, Dann EJ, Lotan H, Ben Yehuda D, et al. (1995) Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease - a report of 4 cases. Ann Oncol 6:777-779
7. Pollicardo N, O'Brien S, Estey EH, al-Bitar M, Pierce S, Keating M, et al. (1996) Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution. Leukemia 10:27-31
8. Detourmignies L, Castaigne S, Stoppa AM, Harousseau JL, Sadoun A, Janvier M, et al. (1992) Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol 10:1430-1435
9. Giagounidis AA, Beckmann MW, Giagounidis AS, Aivado M, Emde T, Germing U, et al. (2000) Acute promyelocytic leukemia and pregnancy. Eur J Haematol 64:267-271
10. Lopes LF, de Camargo B (1999) Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH). Med Pediatr Oncol 32:315
11. Schiavetti A, Varrasso G, Maurizi P, Castello MA (2001) Two secondary leukemias among 15 children given oral etoposide. Med Pediatr Oncol 37:148-149
12. Dufour C, Lanciotti M, Micalizzi C, Valetto A, Haupt R (2001) Non-identical twin sisters concordant for Langerhans cell histiocytosis and discordant for secondary acute promyelocytic leukemia. Med Pediatr Oncol 37:70-72
13. Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R (2001) Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. Am J Hematol 66:274-279
14. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, et al. (1998) The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12:1383-1391
15. Zhang Y, Nie L (2001) Studies of apoptosis of malignant lymphoma cells induced by arsenic trioxide. Cell Biol Int 25:1003-1006
16. Murgo AJ (2001) Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist 6 [Suppl 2]:22-28